Trade Summary

3 days ago, PERSKY MARLA, serving as Dir at Xeris Biopharma Holdings, Inc. (XERS), sold 15,500 shares at $5.90 per share, for a total transaction value of $91,432.95. Following this transaction, PERSKY MARLA now holds 126,500 shares of XERS.

This sale represents a 10.92% decrease in PERSKY MARLA's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, June 3, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 5, 2026 at 6:29 PM ET, 2 days after the trade was made.

Xeris Biopharma Holdings, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.